NCT07798856Not yet recruiting
Effects of a Multidisciplinary Integrated Care Model on Care Outcomes in Patients With Heart Failure With Preserved Ejection Fraction
A Prospective Quasi-Experimental Study With Historical Control to Evaluate the Effects of a Multidisciplinary Integrated Care Model on Care Outcomes in Patients With Heart Failure With Preserved Ejection Fraction
Source: ClinicalTrials.gov · Last updated 1 Sept 2026
Brief summary (registry, in English)
Heart failure with preserved ejection fraction (HFpEF) accounts for approximately half of all heart failure cases and is associated with frequent hospitalizations, poor quality of life, and limited effective treatment options. Fragmented, single-discipline care often fails to address the multiple comorbidities and self-management needs of this population. This study evaluates a Multidisciplinary Integrated Care Model (MICM) for patients with HFpEF, delivered by a coordinated team including cardiologists, case managers, pharmacists, dietitians, and rehabilitation specialists. The intervention group will receive structured team-based care, including regular follow-up, medication optimization, dietary and lifestyle counseling, and exercise guidance, in addition to standard cardiology care. Using a prospective quasi-experimental design with a historical control group, this study compares clinical and patient-reported outcomes between patients receiving the multidisciplinary integrated care model and a historical cohort receiving usual care. The primary aim is to determine whether this integrated care approach improves outcomes such as heart failure-related hospitalization, functional status, and quality of life in patients with HFpEF.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 9 Aug 2026
- Start date
- Aug 2026
- Primary completion date
- Jul 2027
- Lead sponsor
- Chimei Medical Center
- Diseases
- Heart failure
- NCT number
- NCT07798856
What you commit to
- Study type: Interventional
- Planned participants: 200
- From Aug 2026 to the primary completion date, Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe cognitive impairment without a family member or caregiver available to assist with the digital platform
Other
- Patients who elected hospice or palliative care as part of an advance care plan during the index hospitalization
- Anticipated inability to complete post-discharge follow-up or lack of regular follow-up at the study institution's outpatient clinic
- Length of index hospital stay less than 24 hours
Who the study is looking for
- Age 18 years or older
- Hospitalized with a physician diagnosis of heart failure with preserved ejection fraction (HFpEF)
- Left ventricular ejection fraction (LVEF) ≥50% on echocardiography performed during the index hospitalization
- New York Heart Association (NYHA) functional class III to IV
- Able to communicate in Mandarin or Taiwanese and understand the study intervention
- For the prospective intervention group: willing to participate and provide written informed consent. For the historical control group: existing medical record data will be collected under a waiver of informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chi Mei Medical Center Coordinator of this site? Confirm its status | Tainan | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.